New drug RO7806881 put to the test in healthy volunteers
NCT ID NCT07271693
First seen Jan 06, 2026 · Last updated Apr 30, 2026 · Updated 21 times
Summary
This early-stage study is testing a new drug called RO7806881 in 128 healthy adults to see if it is safe and how the body handles it. Participants receive either the drug or a placebo, and researchers monitor for side effects. The goal is to gather safety information before testing the drug in patients with a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research - Christchurch
RECRUITINGChristchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.